188 related articles for article (PubMed ID: 3681193)
1. Elastase-mediated fibrinogenolysis by chemoattractant-stimulated neutrophils occurs in the presence of physiologic concentrations of antiproteinases.
Weitz JI; Huang AJ; Landman SL; Nicholson SC; Silverstein SC
J Exp Med; 1987 Dec; 166(6):1836-50. PubMed ID: 3681193
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases.
Evangelista V; Rajtar G; de Gaetano G; White JG; Cerletti C
Blood; 1991 Jun; 77(11):2379-88. PubMed ID: 1645603
[TBL] [Abstract][Full Text] [Related]
3. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane.
Delclaux C; Delacourt C; D'Ortho MP; Boyer V; Lafuma C; Harf A
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):288-95. PubMed ID: 8845180
[TBL] [Abstract][Full Text] [Related]
4. Fibrin regulates neutrophil migration in response to interleukin 8, leukotriene B4, tumor necrosis factor, and formyl-methionyl-leucyl-phenylalanine.
Loike JD; el Khoury J; Cao L; Richards CP; Rascoff H; Mandeville JT; Maxfield FR; Silverstein SC
J Exp Med; 1995 May; 181(5):1763-72. PubMed ID: 7722453
[TBL] [Abstract][Full Text] [Related]
5. Development of an assay for in vivo human neutrophil elastase activity. Increased elastase activity in patients with alpha 1-proteinase inhibitor deficiency.
Weitz JI; Landman SL; Crowley KA; Birken S; Morgan FJ
J Clin Invest; 1986 Jul; 78(1):155-62. PubMed ID: 3487555
[TBL] [Abstract][Full Text] [Related]
6. Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.
Kazura JW; Wenger JD; Salata RA; Budzynski AZ; Goldsmith GH
J Clin Invest; 1989 Jun; 83(6):1916-24. PubMed ID: 2542377
[TBL] [Abstract][Full Text] [Related]
7. An enzyme immunoassay for polymorphonuclear leucocyte-mediated fibrinogenolysis.
Bos R; van Leuven CJ; Stolk J; Hiemstra PS; Ronday HK; Nieuwenhuizen W
Eur J Clin Invest; 1997 Feb; 27(2):148-56. PubMed ID: 9061309
[TBL] [Abstract][Full Text] [Related]
8. The role of fibrin degradation products in neutrophil recruitment to the lung.
Leavell KJ; Peterson MW; Gross TJ
Am J Respir Cell Mol Biol; 1996 Jan; 14(1):53-60. PubMed ID: 8534486
[TBL] [Abstract][Full Text] [Related]
9. Regulation of neutrophil functions by elastase-generated IgG fragments.
Eckle I; Kolb G; Havemann K
Arch Immunol Ther Exp (Warsz); 1992; 40(1):43-7. PubMed ID: 1336654
[TBL] [Abstract][Full Text] [Related]
10. Potency of antileukoprotease and alpha 1-antitrypsin to inhibit degradation of fibrinogen by adherent polymorphonuclear leukocytes from normal subjects and patients with chronic granulomatous disease.
Stolk J; Davies P; Kramps JA; Dijkman JH; Humes JJ; Knight WB; Green BG; Mumford R; Bonney RJ; Hanlon WA
Am J Respir Cell Mol Biol; 1992 May; 6(5):521-6. PubMed ID: 1316132
[TBL] [Abstract][Full Text] [Related]
11. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.
Senior RM; Skogen WF; Griffin GL; Wilner GD
J Clin Invest; 1986 Mar; 77(3):1014-9. PubMed ID: 3005361
[TBL] [Abstract][Full Text] [Related]
12. A derivative of wheat germ agglutinin specifically inhibits formyl-peptide-induced polymorphonuclear leukocyte chemotaxis by blocking re-expression (or recycling) of receptors.
Perez HD; Elfman F; Lobo E; Sklar L; Chenoweth D; Hooper C
J Immunol; 1986 Mar; 136(5):1803-12. PubMed ID: 3753993
[TBL] [Abstract][Full Text] [Related]
13. Co-incubation of PMN and CaCo-2 cells modulates inflammatory potential.
Schaefer MB; Schaefer CA; Hecker M; Morty RE; Witzenrath M; Seeger W; Mayer K
Cell Mol Biol (Noisy-le-grand); 2017 May; 63(5):119-126. PubMed ID: 28719356
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen-derived peptide B beta 1-42 is a multidomained neutrophil chemoattractant.
Skogen WF; Senior RM; Griffin GL; Wilner GD
Blood; 1988 May; 71(5):1475-9. PubMed ID: 3359049
[TBL] [Abstract][Full Text] [Related]
15. Cleavage of membrane-bound C3b and C3bi by viable human neutrophils (PMN).
Gaither TA; Hammer CH; Gadek JE; Katusha K; Santaella M; Frank MM
Mol Immunol; 1983 Jun; 20(6):623-35. PubMed ID: 6603572
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of the chemotactic activity of heparin cofactor II proteolysis products.
Hoffman M; Pratt CW; Corbin LW; Church FC
J Leukoc Biol; 1990 Aug; 48(2):156-62. PubMed ID: 2196322
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 stimulates degranulation and oxidant release by adherent human neutrophils.
Balazovich KJ; Fernandez R; Hinkovska-Galcheva V; Suchard SJ; Boxer LA
J Leukoc Biol; 1996 Dec; 60(6):772-7. PubMed ID: 8975881
[TBL] [Abstract][Full Text] [Related]
18. Shedding of tumor necrosis factor receptors by activated human neutrophils.
Porteu F; Nathan C
J Exp Med; 1990 Aug; 172(2):599-607. PubMed ID: 2165128
[TBL] [Abstract][Full Text] [Related]
19. A monoclonal antibody with high affinity for a neo-antigenic site in fibrinogen degraded by polymorphonuclear leukocyte-derived elastase.
Bos R; van Leuven CJ; Stolk J; Hiemstra PS; Dijkman JH; Nieuwenhuizen W
Blood Coagul Fibrinolysis; 1995 May; 6(3):259-67. PubMed ID: 7544637
[TBL] [Abstract][Full Text] [Related]
20. Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization.
Campbell EJ; Campbell MA
J Cell Biol; 1988 Mar; 106(3):667-76. PubMed ID: 3279049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
